Medicus Pharma (NASDAQ:MDCX) earlier this week outlined further progress in its Skinject program following the release of Phase 2 topline data, alongside independent validation from a leading ...

SkinJect™ , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...

Doctors share stories of patients who came in for routine checkups but ended up needing major surgery, showing how ...

Popular New York City meteorologist Sam Champion is returning to "Good Morning America" after needing an unexpected heart ...

A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

Belinda Shipman told Newsweek that the month-long treatment felt like her "face, body and mind were literally being torn ...

Katlein Franca, MD, is a dermatologist and clinical associate professor of Dermatology & Cutaneous Surgery and Psychiatry & Behavioral Sciences at the University of Miami. Basal cell carcinoma often ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin icodec-abae is a 700 U/mL injectable insulin ...

Shares of Arm Holdings plc (Nasdaq: ARM) are surging this morning after the semiconductor design firm announced it will begin making its own chips for AI workloads. The move from chip designer to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Arm Holdings announced its first chip product, the Arm AGI CPU. The new data center ...